| Date Filed | Type | Description |
| 06/16/2023 |
4
| Koppikar Utpal (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 26,000 options to buy
@ $3.61, valued at
$93.9k
|
|
| 03/06/2023 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 6,871 shares
@ $3.627, valued at
$24.9k
|
|
| 02/09/2023 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 2,485 shares
@ $5.46, valued at
$13.6k
|
|
| 11/18/2022 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 5,172 shares
@ $4.49, valued at
$23.2k
Sold 1,083 shares
@ $4.491, valued at
$4.9k
|
|
| 08/18/2022 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 5,940 shares
@ $5.035, valued at
$29.9k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2022 |
4
| Koppikar Utpal (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 41,200 options to buy
@ $22.64, valued at
$932.8k
|
|
| 03/17/2022 |
3
| Koppikar Utpal (Director) has filed a Form 3 on C4 Therapeutics, Inc. |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2022 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 2,496 shares
@ $14.4615, valued at
$36.1k
|
|
| 11/19/2021 |
4
| Koppikar Utpal (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 32,000 options to buy
@ $7.82, valued at
$250.2k
|
|
| 11/18/2021 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 3,655 shares
@ $17.1169, valued at
$62.6k
|
|
| 07/12/2021 |
4
| Koppikar Utpal (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 32,000 options to buy
@ $7.82, valued at
$250.2k
|
|
| 07/12/2021 |
3
| Koppikar Utpal (Director) has filed a Form 3 on Flexion Therapeutics Inc |
| 06/09/2021 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 5,820 shares
@ $14.06, valued at
$81.8k
|
|
| 05/20/2021 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 3,616 shares
@ $14.55, valued at
$52.6k
|
|
| 03/30/2021 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 1,761 shares
@ $14.58, valued at
$25.7k
|
|
| 03/04/2021 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 1,461 shares
@ $16.74, valued at
$24.5k
|
|
| 03/03/2021 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 45,258 shares
@ $0
Granted 68,314 options to buy
@ $17.105, valued at
$1.2M
|
|
| 02/09/2021 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 1,759 shares
@ $20.39, valued at
$35.9k
|
|
| 11/18/2020 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 1,469 shares
@ $19.774, valued at
$29k
|
|
| 08/20/2020 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 1,496 shares
@ $12.09, valued at
$18.1k
|
|
| 06/10/2020 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 3,924 shares
@ $10.18, valued at
$39.9k
|
|
| 05/20/2020 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 1,428 shares
@ $11.22, valued at
$16k
|
|
| 03/30/2020 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 1,827 shares
@ $9.17, valued at
$16.8k
|
|
| 03/03/2020 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 66,875 shares
@ $0
Granted 73,750 options to buy
@ $12.15, valued at
$896.1k
|
|
| 02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2019 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 02/08/2019 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 17,063 shares
@ $0
Granted 34,125 options to buy
@ $38.47, valued at
$1.3M
|
|
| 09/11/2018 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Bought 2,000 shares
@ $36.8, valued at
$73.6k
|
|
| 06/07/2018 |
4
| Koppikar Utpal (CFO) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 45,000 shares
@ $0
Granted 75,000 options to buy
@ $42.3, valued at
$3.2M
|
|
| 06/07/2018 |
3
| Koppikar Utpal (CFO) has filed a Form 3 on Atara Biotherapeutics, Inc. |